Articles By Anuja Singh

How Will Eli Lilly’s New $220,000 sq ft Hyderabad Tech Hub and 1,500-Strong AI Workforce Transform Global Biopharma Innovation?

Key Highlights Strategic Digital Operations Hub Anchors Eli Lilly’s Global Innovation AmbitionsEli Lilly’s Hyderabad facility located in Gachibowli…

ByByAnuja SinghAug 5, 2025
Is AbbVie’s $15.4 Billion Q2 Surge and Strategic External Innovation Pipeline Redefining Big Pharma’s…

Key Highlights Strong Q2 Financial Performance and Guidance RaiseAbbVie reported Q2 2025 net revenues of $15.423 billion, up…

ByByAnuja SinghAug 5, 2025
How Will METiS Technologies’ RMB 400 Million Series D Raise Accelerate Beijing’s AI-Powered Nanodelivery…

Key Highlights Strong Capital Infusion to Accelerate AI-Driven Nanotechnology DevelopmentThe recent RMB 400 million (~$57 million) financing round…

ByByAnuja SinghAug 5, 2025
How Will Lantern Pharma’s PredictBBB.ai Advance with 94% Accuracy Revolutionize CNS Drug Development?

Key Highlights Breakthrough AI Methodology Sets New Industry BenchmarkLantern’s proprietary ensemble of machine learning algorithms—including logistic regression, random…

ByByAnuja SinghAug 4, 2025
Can Phare Bio’s AI-Driven Antibiotic Discovery Win Herald a New Era in Combating Antimicrobial…

Key Highlights Harnessing Generative AI to Revolutionize Antibiotic DiscoveryPhare Bio leverages cutting-edge AI to drastically shorten the traditionally…

ByByAnuja SinghAug 4, 2025
Will AbbVie’s $1 Billion Move to Acquire Gilgamesh Pioneer a New Era in Mental…

Key Highlights Advanced Acquisition Talks Reflect Growth Strategy Amid Sector InterestAbbVie, following over $20 billion in acquisitions since…

ByByAnuja SinghAug 1, 2025
Image Not Found
How Will Eli Lilly’s New $220,000 sq ft Hyderabad Tech Hub and 1,500-Strong AI Workforce Transform Global Biopharma Innovation?

Key Highlights Strategic Digital Operations Hub Anchors Eli Lilly’s Global Innovation AmbitionsEli Lilly’s Hyderabad facility located in Gachibowli…

ByByAnuja SinghAug 5, 2025
Is AbbVie’s $15.4 Billion Q2 Surge and Strategic External Innovation Pipeline Redefining Big Pharma’s…

Key Highlights Strong Q2 Financial Performance and Guidance RaiseAbbVie reported Q2 2025 net revenues of $15.423 billion, up…

ByByAnuja SinghAug 5, 2025
How Will METiS Technologies’ RMB 400 Million Series D Raise Accelerate Beijing’s AI-Powered Nanodelivery…

Key Highlights Strong Capital Infusion to Accelerate AI-Driven Nanotechnology DevelopmentThe recent RMB 400 million (~$57 million) financing round…

ByByAnuja SinghAug 5, 2025
How Will Lantern Pharma’s PredictBBB.ai Advance with 94% Accuracy Revolutionize CNS Drug Development?

Key Highlights Breakthrough AI Methodology Sets New Industry BenchmarkLantern’s proprietary ensemble of machine learning algorithms—including logistic regression, random…

ByByAnuja SinghAug 4, 2025
Can Phare Bio’s AI-Driven Antibiotic Discovery Win Herald a New Era in Combating Antimicrobial…

Key Highlights Harnessing Generative AI to Revolutionize Antibiotic DiscoveryPhare Bio leverages cutting-edge AI to drastically shorten the traditionally…

ByByAnuja SinghAug 4, 2025
Will AbbVie’s $1 Billion Move to Acquire Gilgamesh Pioneer a New Era in Mental…

Key Highlights Advanced Acquisition Talks Reflect Growth Strategy Amid Sector InterestAbbVie, following over $20 billion in acquisitions since…

ByByAnuja SinghAug 1, 2025
Scroll to Top